{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T08:14:17Z","timestamp":1779264857764,"version":"3.51.4"},"reference-count":62,"publisher":"MDPI AG","issue":"16","license":[{"start":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T00:00:00Z","timestamp":1629331200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJERPH"],"abstract":"<jats:p>To compare the rate and risk of ovarian cancer in patients with endometriosis or pelvic inflammatory disease (PID). A nationwide population cohort research compared the risk of ovarian cancer in 135,236 age-matched comparison females, 114,726 PID patients, and 20,510 endometriosis patients out of 982,495 females between 1 January 2002 and 31 December 2014 and ended on the date of confirmation of ovarian cancer, death, or 31 December 2014. In order to reduce the unbalanced characteristics, propensity score matching (PSM) was performed for 20,478 females in each subgroup. The incidence rate (per 100,000 person\u2013years) of ovarian cancer was 8.74 (95% CI, 7.16\u201310.66) in comparison, 9.26 (7.54\u201311.39) in PID, and 28.73 (21.07\u201339.16) in endometriosis cohorts. The adjusted hazard ratio (aHR) of ovarian cancer was 1.17 (p = 0.296) in PID and 3.12 (p &lt; 0.001) in endometriosis cohorts, compared with the comparison cohort in full cohort, using the multiple Cox regression model. The aHR of ovarian cancer was 0.83 (p = 0.650) in PID and 3.03 (p = 0.001) in endometriosis cohorts, compared with the comparison cohort after performing PSM. In the full cohort and PSM population, the cumulative incidence rate of ovarian cancer was significantly higher in patients with endometriosis than in those with PID or in the comparison cohort (p &lt; 0.001 and p &lt; 0.001). In conclusion, after considering the differences in the impacts of exposure to endometriosis or PID, patients with endometriosis were more likely to develop ovarian cancer.<\/jats:p>","DOI":"10.3390\/ijerph18168754","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T09:58:06Z","timestamp":1629367086000},"page":"8754","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Different Influences of Endometriosis and Pelvic Inflammatory Disease on the Occurrence of Ovarian Cancer"],"prefix":"10.3390","volume":"18","author":[{"given":"Jing-Yang","family":"Huang","sequence":"first","affiliation":[{"name":"Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan"},{"name":"Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0365-7927","authenticated-orcid":false,"given":"Shun-Fa","family":"Yang","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan"},{"name":"Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei-Ju","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan"},{"name":"Department of Obstetrics and Gynecology, Chung Shan Medical University Hospital, Taichung 402, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Hao","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Medicine, National Taiwan University, Taipei 106, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7113-8352","authenticated-orcid":false,"given":"Chih-Hsin","family":"Tang","sequence":"additional","affiliation":[{"name":"School of Medicine, China Medical University, Taichung 404, Taiwan"},{"name":"Chinese Medicine Research Center, China Medical University, Taichung 404, Taiwan"},{"name":"Department of Medical Laboratory Science and Biotechnology, College of Medical and Health Science, Asia University, Taichung 413, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Hui","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Medicine, Chung Shan Medical University, Taichung 402, Taiwan"},{"name":"Department of Medical Research, Chung Shan Medical University Hospital, Taichung 402, Taiwan"},{"name":"Department of Obstetrics and Gynecology, Chung Shan Medical University Hospital, Taichung 402, Taiwan"},{"name":"School of Medicine, Chung Shan Medical University, Taichung 402, Taiwan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,8,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/ijc.23173","article-title":"Inflammation and cancer: An ancient link with novel potentials","volume":"121","author":"Hussain","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1574-695X.2000.tb01410.x","article-title":"Mycoplasmal infections alter gene expression in cultured human prostatic and cervical epithelial cells","volume":"27","author":"Zhang","year":"2000","journal-title":"FEMS Immunol. Med. Microbiol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"McGowin, C.L., Popov, V.L., and Pyles, R.B. (2009). Intracellular mycoplasma genitalium infection of human vaginal and cervical epithelial cells elicits distinct patterns of inflammatory cytokine secretion and provides a possible survival niche against macrophage-mediated killing. BMC Microbiol., 9.","DOI":"10.1186\/1471-2180-9-139"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0015-0282(02)02959-X","article-title":"Oxidative stress and peritoneal endometriosis","volume":"77","author":"Donnez","year":"2002","journal-title":"Fertil. Steril."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/431405a","article-title":"Cancer: An inflammatory link","volume":"431","author":"Balkwill","year":"2004","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: Back to virchow?","volume":"357","author":"Balkwill","year":"2001","journal-title":"Lancet"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1158\/1541-7786.MCR-05-0261","article-title":"Inflammation, a key event in cancer development","volume":"4","author":"Lu","year":"2006","journal-title":"Mol. Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMcp1000274","article-title":"Clinical practice. Endometriosis","volume":"362","author":"Giudice","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/1471-0528.14711","article-title":"Epidemiology of endometriosis: A large population-based database study from a healthcare provider with 2 million members","volume":"125","author":"Eisenberg","year":"2018","journal-title":"BJOG"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1159\/000052874","article-title":"Malignant transformation of ovarian endometriosis","volume":"50","author":"Nishida","year":"2000","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0002-9378(97)70550-7","article-title":"Cancer risk after a hospital discharge diagnosis of endometriosis","volume":"176","author":"Brinton","year":"1997","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.21037\/atm-20-3022a","article-title":"Endometriosis-associated ovarian carcinomas: Insights into pathogenesis, diagnostics, and therapeutic targets\u2014A narrative review","volume":"8","author":"Samartzis","year":"2020","journal-title":"Ann. Transl. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s10552-017-0856-4","article-title":"Endometriosis and risk of ovarian and endometrial cancers in a large prospective cohort of U.S. Nurses","volume":"28","author":"Poole","year":"2017","journal-title":"Cancer Causes Control"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra1411426","article-title":"Pelvic inflammatory disease","volume":"372","author":"Brunham","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_15","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines, 2015","volume":"64","author":"Workowski","year":"2015","journal-title":"MMWR Recomm. Rep."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/OLQ.0b013e318285ce46","article-title":"Correlates of self-reported pelvic inflammatory disease treatment in sexually experienced reproductive-aged women in the united states, 1995 and 2006-2010","volume":"40","author":"Leichliter","year":"2013","journal-title":"Sex. Transm. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10552-013-0216-y","article-title":"Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors","volume":"24","author":"Rasmussen","year":"2013","journal-title":"Cancer Causes Control"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1097\/IGC.0000000000000235","article-title":"Pelvic inflammation and the pathogenesis of ovarian cancer: A cohort study","volume":"24","author":"McAlpine","year":"2014","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/ijc.24091","article-title":"Markers of inflammation and risk of ovarian cancer in los angeles county","volume":"124","author":"Wu","year":"2009","journal-title":"Int. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/aje\/kwp314","article-title":"Risk factors for epithelial ovarian cancer by histologic subtype","volume":"171","author":"Gates","year":"2010","journal-title":"Am. J. Epidemiol."},{"key":"ref_21","unstructured":"Ministry of Health and Welfare (2020, June 04). The 2000 and 2005 Longitudinal Generation Tracking Database (lgtd 2000, lgtd 2005) Establishment and Verification Report for 2 Million Sampled People, Available online: https:\/\/www.mohw.gov.tw\/dl-60195-6df3ea41-d86b-4d52-b98a-90ce58fa7195.html."},{"key":"ref_22","unstructured":"International Association of Cancer Registries (2020, June 04). Taiwan Cancer Registry Profile Page. Available online: http:\/\/www.iacr.com.fr\/index.php?option=com_comprofiler&task=userprofile&user=1440&Itemid=498."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3083","DOI":"10.1002\/sim.3697","article-title":"Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples","volume":"28","author":"Austin","year":"2009","journal-title":"Stat. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S2213-8587(17)30258-9","article-title":"Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (cvd-real nordic): A multinational observational analysis","volume":"5","author":"Birkeland","year":"2017","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.ygyno.2017.06.011","article-title":"Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes","volume":"146","author":"Arima","year":"2017","journal-title":"Gynecol. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"l1204","DOI":"10.1136\/bmj.l1204","article-title":"Incidence of type 2 diabetes mellitus in men receiving steroid 5alpha-reductase inhibitors: Population based cohort study","volume":"365","author":"Wei","year":"2019","journal-title":"BMJ"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1001\/jama.2016.7789","article-title":"Prescription of long-acting opioids and mortality in patients with chronic noncancer pain","volume":"315","author":"Ray","year":"2016","journal-title":"JAMA"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1093\/humrep\/dei462","article-title":"Endometriosis and the risk of cancer with special emphasis on ovarian cancer","volume":"21","author":"Melin","year":"2006","journal-title":"Hum. Reprod."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.fertnstert.2004.02.109","article-title":"Ovarian cancer risk associated with varying causes of infertility","volume":"82","author":"Brinton","year":"2004","journal-title":"Fertil. Steril."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/j.1525-1438.2006.00754.x","article-title":"Risk of developing ovarian cancer among women with ovarian endometrioma: A cohort study in shizuoka, japan","volume":"17","author":"Kobayashi","year":"2007","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/cncr.10370","article-title":"Postmenopausal cancer risk after self-reported endometriosis diagnosis in the iowa women\u2019s health study","volume":"94","author":"Olson","year":"2002","journal-title":"Cancer"},{"key":"ref_32","first-page":"40","article-title":"Frequency of endometriosis and adenomyosis in patients with leiomyomas, gynecologic premalignant, and malignant neoplasias","volume":"40","author":"Nomelini","year":"2013","journal-title":"Clin. Exp. Obstet. Gynecol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1470-2045(11)70404-1","article-title":"Association between endometriosis and risk of histological subtypes of ovarian cancer: A pooled analysis of case-control studies","volume":"13","author":"Pearce","year":"2012","journal-title":"Lancet Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/aogs.12255","article-title":"The relation between endometriosis and ovarian cancer\u2014A review","volume":"93","author":"Heidemann","year":"2014","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Hermens, M., van Altena, A.M., Bulten, J., van Vliet, H.A.A.M., Siebers, A.G., and Bekkers, R.L.M. (2021). Increased incidence of ovarian cancer in both endometriosis and adenomyosis. Gynecol. Oncol.","DOI":"10.1136\/ijgc-2021-IGCS.299"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1038\/bjc.2014.29","article-title":"Risk and prognosis of ovarian cancer in women with endometriosis: A meta-analysis","volume":"110","author":"Kim","year":"2014","journal-title":"Br. J. Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.bpobgyn.2018.01.017","article-title":"Perimenopausal management of ovarian endometriosis and associated cancer risk: When is medical or surgical treatment indicated?","volume":"51","author":"Vercellini","year":"2018","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2020.01.041","article-title":"Incidence of endometrioid and clear-cell ovarian cancer in histological proven endometriosis: The ENOCA population-based cohort study","volume":"223","author":"Hermens","year":"2020","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1093\/hmg\/ddv306","article-title":"Shared genetics underlying epidemiological association between endometriosis and ovarian cancer","volume":"24","author":"Lu","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"ref_40","first-page":"642","article-title":"Loss of arid1a\/baf250a expression in ovarian endometriosis and clear cell carcinoma","volume":"5","author":"Xiao","year":"2012","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"14754","DOI":"10.18632\/oncotarget.24546","article-title":"Affinity-purified DNA-based mutation profiles of endometriosis-related ovarian neoplasms in japanese patients","volume":"9","author":"Ishikawa","year":"2018","journal-title":"Oncotarget"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"18824","DOI":"10.3390\/ijms140918824","article-title":"Arid1a mutations and pi3k\/akt pathway alterations in endometriosis and endometriosis-associated ovarian carcinomas","volume":"14","author":"Samartzis","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"ref_43","first-page":"155","article-title":"Endometriosis and ovarian cancer: Clinical and molecular aspects","volume":"39","author":"Pavlidou","year":"2014","journal-title":"Minerva Endocrinol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.humpath.2011.10.009","article-title":"Kras mutations in ovarian low-grade endometrioid adenocarcinoma: Association with concurrent endometriosis","volume":"43","author":"Stewart","year":"2012","journal-title":"Hum. Pathol."},{"key":"ref_45","first-page":"1465348","article-title":"Endometriosis malignant transformation: Epigenetics as a probable mechanism in ovarian tumorigenesis","volume":"2018","author":"He","year":"2018","journal-title":"Int. J. Genom."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1023\/A:1015587423262","article-title":"Tumors and inflammatory infiltrates: Friends or foes?","volume":"19","author":"Brigati","year":"2002","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing","volume":"315","author":"Dvorak","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1006\/smim.2000.0210","article-title":"The i kappa b kinase (ikk) and nf-kappa b: Key elements of proinflammatory signalling","volume":"12","author":"Karin","year":"2000","journal-title":"Semin. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neubiorev.2003.11.010","article-title":"Neurochemical and behavioral studies on ethanol and nicotine interactions","volume":"27","author":"Larsson","year":"2004","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"293","DOI":"10.17772\/gp\/1579","article-title":"Inflammation and ovarian cancer\u2014Current views","volume":"84","author":"Kisielewski","year":"2013","journal-title":"Ginekol. Pol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1470-2045(11)70165-6","article-title":"Risk of ovarian cancer in women with pelvic inflammatory disease: A population-based study","volume":"12","author":"Lin","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.ygyno.2020.02.002","article-title":"Association between pelvic inflammatory disease and risk of ovarian cancer: An updated meta-analysis","volume":"157","author":"Piao","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s10552-017-0873-3","article-title":"Pelvic inflammatory disease and the risk of ovarian cancer: A meta-analysis","volume":"28","author":"Zhou","year":"2017","journal-title":"Cancer Causes Control"},{"key":"ref_55","first-page":"667","article-title":"Pelvic inflammatory disease and risk of ovarian cancer","volume":"5","author":"Parazzini","year":"1996","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1093\/aje\/kww161","article-title":"Pelvic inflammatory disease and the risk of ovarian cancer and borderline ovarian tumors: A pooled analysis of 13 case-control studies","volume":"185","author":"Rasmussen","year":"2017","journal-title":"Am. J. Epidemiol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Shen, C.C., Hu, L.Y., Yang, A.C., Chiang, Y.Y., Hung, J.H., and Tsai, S.J. (2016). Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: A nationwide population-based retrospective cohort study. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2857-1"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1056\/NEJMoa1614814","article-title":"Cancer-Associated Mutations in Endometriosis without Cancer","volume":"376","author":"Anglesio","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/modpathol.2011.189","article-title":"Loss of ARID1A protein expression occurs as an early event in ovarian clear-cell carcinoma development and frequently coexists with PIK3CA mutations","volume":"25","author":"Yamamoto","year":"2011","journal-title":"Mod. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ijgo.2015.02.021","article-title":"The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis","volume":"130","author":"Chene","year":"2015","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/aje\/kwq481","article-title":"Bias due to left truncation and left censoring in longitudinal studies of developmental and disease processes","volume":"173","author":"Cain","year":"2011","journal-title":"Am. J. Epidemiol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ijgo.13066","article-title":"Pelvic inflammatory disease and risk of cancer: A nationwide cohort study","volume":"149","author":"Sogaard","year":"2020","journal-title":"Int. J. Gynaecol. Obstet."}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/16\/8754\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T06:47:15Z","timestamp":1760165235000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/18\/16\/8754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,19]]},"references-count":62,"journal-issue":{"issue":"16","published-online":{"date-parts":[[2021,8]]}},"alternative-id":["ijerph18168754"],"URL":"https:\/\/doi.org\/10.3390\/ijerph18168754","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,19]]}}}